S. Della Torre

Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: A case report

G. Manes, G. de Nucci, R. Bollina, 2021, World journal of clinical oncology.

Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?

L. Mariani, S. Iacobelli, J. Rosai, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumors.

G. Lucignani, E. Seregni, E. Bombardieri, 2004, The International journal of biological markers.

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

V. Torri, L. Cortesi, E. Rulli, 2016, Breast Cancer Research and Treatment.

Current Treatments of Neuroendocrine Tumors Role of Biotherapy and Chemotherapy

A. Denaro, G. Procopio, E. Bajetta, 2003, Tumori.

A randomized, multicenter prospective trial assessing long‐acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma

G. Procopio, D. Alberti, N. Zilembo, 2002, Cancer.

Long-term complete response in metastatic poorly-differentiated neuroendocrine rectal carcinoma with a multimodal approach: A case report

G. Manes, G. de Nucci, R. Bollina, 2021, Endoscopy.

Safety and efficacy of two different doses of capecitabine in the treatment of advanced breast cancer in older women.

L. Mariani, L. Gattinoni, G. Procopio, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.